lapatinib has been researched along with toxoflavin in 1 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (toxoflavin) | Trials (toxoflavin) | Recent Studies (post-2010) (toxoflavin) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 82 | 0 | 53 |
| Protein | Taxonomy | lapatinib (IC50) | toxoflavin (IC50) |
|---|---|---|---|
| 90-kda heat shock protein beta HSP90 beta, partial | Homo sapiens (human) | 1.0566 | |
| Cathepsin B | Homo sapiens (human) | 0.0461 | |
| procathepsin L isoform 1 preproprotein | Homo sapiens (human) | 0.2258 | |
| cathepsin S isoform 1 preproprotein | Homo sapiens (human) | 0.1765 | |
| dual specificity protein phosphatase 3 | Homo sapiens (human) | 1.36 | |
| heat shock protein HSP 90-alpha isoform 2 | Homo sapiens (human) | 1.0566 | |
| tyrosine-protein phosphatase non-receptor type 22 isoform 1 | Homo sapiens (human) | 1.295 | |
| dual specificity protein phosphatase 6 | Rattus norvegicus (Norway rat) | 2.32 | |
| tyrosine-protein phosphatase non-receptor type 7 isoform 2 | Homo sapiens (human) | 1.24 | |
| Lysine-specific demethylase 4A | Homo sapiens (human) | 2.5 | |
| Transcription factor 4 | Homo sapiens (human) | 0.8 | |
| Catenin beta-1 | Homo sapiens (human) | 5.4 | |
| NAD-dependent protein deacetylase sirtuin-1 | Homo sapiens (human) | 0.87 | |
| Lysine-specific demethylase 4C | Homo sapiens (human) | 0.5205 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Liu, BR; Xie, L | 1 |
1 review(s) available for lapatinib and toxoflavin
| Article | Year |
|---|---|
[Stem cell-targeted therapy--a new strategy for cancer treatment].
Topics: Adenosine; Animals; Antineoplastic Agents; ATP-Binding Cassette Transporters; Biomarkers, Tumor; Cell Differentiation; Diketopiperazines; Heterocyclic Compounds, 4 or More Rings; Humans; Lapatinib; Neoplasms; Neoplastic Stem Cells; Protein Kinase Inhibitors; Pyrimidinones; Quinazolines; Signal Transduction; Triazines; Wnt Proteins | 2008 |